![](/images/graphics-bg.png)
Neoadjuvant Chemotherapy Use in Bladder Cancer : A Survey of Current Practice and Opinions
المؤلفون المشاركون
Amling, C. L.
Chen, Y.
Apolo, A. B.
Koppie, T. M.
La Rochelle, J. C.
Downs, Tracy M.
Bochner, B. H.
Porter, Michael P.
Cowan, N. G.
المصدر
العدد
المجلد 2014، العدد 2014 (31 ديسمبر/كانون الأول 2014)، ص ص. 1-6، 6ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2014-05-28
دولة النشر
مصر
عدد الصفحات
6
التخصصات الرئيسية
الملخص EN
Objectives.
Level 1 evidence supports the use of neoadjuvant chemotherapy (NAC) to improve overall survival in muscle invasive bladder cancer; however utilization rates remain low.
The aims of our study were to determine factors associated with NAC use, to more clearly define reasons for low utilization, and to determine the current rate of NAC use among urologic oncologists.
Materials and Methods.
Active members of the Society for Urologic Oncology were provided a 20-question survey.
Descriptive statistical analysis was conducted for each question and univariate analysis was performed.
Results.
We achieved a response rate of 21%.
Clinical T3/T4 disease was the most often selected reason for recommending NAC (87%).
Concerns with recommending NAC were age and comorbidities (54%) followed by delay in surgery (35%).
An association was identified between urologic oncologists who discussed NAC with >90% of their patients and medical oncologists “always” recommending NAC (P=0.0009).
NAC utilization rate was between 30 and 57%.
Conclusions.
Amongst this highly specialized group of respondents, clinical T3-T4 disease was the most common reason for implementation of NAC.
Respondents who frequently discussed NAC were more likely to report their medical oncologist always recommending NAC.
Reported NAC use was higher in this surveyed group (30–57%) compared with recently published rates.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Cowan, N. G.& Chen, Y.& Downs, Tracy M.& Bochner, B. H.& Apolo, A. B.& Porter, Michael P.…[et al.]. 2014. Neoadjuvant Chemotherapy Use in Bladder Cancer : A Survey of Current Practice and Opinions. Advances in Urology،Vol. 2014, no. 2014, pp.1-6.
https://search.emarefa.net/detail/BIM-495396
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Cowan, N. G.…[et al.]. Neoadjuvant Chemotherapy Use in Bladder Cancer : A Survey of Current Practice and Opinions. Advances in Urology No. 2014 (2014), pp.1-6.
https://search.emarefa.net/detail/BIM-495396
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Cowan, N. G.& Chen, Y.& Downs, Tracy M.& Bochner, B. H.& Apolo, A. B.& Porter, Michael P.…[et al.]. Neoadjuvant Chemotherapy Use in Bladder Cancer : A Survey of Current Practice and Opinions. Advances in Urology. 2014. Vol. 2014, no. 2014, pp.1-6.
https://search.emarefa.net/detail/BIM-495396
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-495396
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
![](/images/ebook-kashef.png)
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر
![](/images/kashef-image.png)